MALDI Mass Spectrometry Imaging Linked with Top-Down Proteomics as a Tool to Study the Non-Small-Cell Lung Cancer Tumor Microenvironment
Open Access
- 28 May 2019
- journal article
- research article
- Published by MDPI AG in Methods and Protocols
- Vol. 2 (2) , 44
Abstract
Advanced non-small-cell lung cancer (NSCLC) is generally linked with a poor prognosis and is one of the leading causes of cancer-related deaths worldwide. Since only a minority of the patients respond well to chemotherapy and/or targeted therapies, immunotherapy might be a valid alternative in the lung cancer treatment field, as immunotherapy attempts to strengthen the body’s own immune response to recognize and eliminate malignant tumor cells. However, positive response patterns to immunotherapy remain unclear. In this study, we demonstrate how immune-related factors could be visualized from single NSCLC tissue sections (Biobank@UZA) while retaining their spatial information by using matrix assisted laser desorption/ionization (MALDI) mass spectrometry imaging (MSI), in order to unravel the molecular profile of NSCLC patients. In this way, different regions in lung cancerous tissues could be discriminated based on the molecular composition. In addition, we linked visualization (MALDI MSI) and identification (based on liquid chromatography higher resolution mass spectrometry) of the molecules of interest for the correct biological interpretation of the observed molecular differences within the area in which these molecules are detected. This is of major importance to fully understand the underlying molecular profile of the NSCLC tumor microenvironment.Keywords
Funding Information
- Fonds Wetenschappelijk Onderzoek (G0E7816N)
This publication has 49 references indexed in Scilit:
- Current Status and Future Perspectives of Mass Spectrometry ImagingInternational Journal of Molecular Sciences, 2013
- Targeting immunosuppression for cancer therapyJournal of Clinical Investigation, 2013
- Mass spectrometry imaging with high resolution in mass and spaceHistochemistry and Cell Biology, 2013
- MALDI Imaging of Lipid Biochemistry in Tissues by Mass SpectrometryChemical Reviews, 2011
- Matrix Sublimation/Recrystallization for Imaging Proteins by Mass Spectrometry at High Spatial ResolutionAnalytical Chemistry, 2011
- Mass Spectrometric Imaging for Biomedical Tissue AnalysisChemical Reviews, 2010
- Sample preparation issues for tissue imaging by imaging MSProteomics, 2009
- PD‐1 signaling in primary T cellsImmunological Reviews, 2009
- Enhancement of protein sensitivity for MALDI imaging mass spectrometry after chemical treatment of tissue sectionsJournal of the American Society for Mass Spectrometry, 2008
- Counting the costs of cancer therapyEuropean Journal of Cancer and Clinical Oncology, 1982